Transaction in Own Shares

Summary by AI BETAClose X

Legal & General Group Plc has purchased 4,787,862 of its ordinary shares between September 1st and September 4th, 2026, as part of its share buyback program announced on March 11th, 2026. These repurchased shares will be cancelled, reducing the total number of ordinary shares in issue to 5,480,446,722, with a corresponding total number of voting rights. The purchases were executed through its broker, Barclays Capital Securities Limited, with prices ranging from 285.70 pence to 295.30 pence per share.

Disclaimer*

Legal & General Group Plc
07 September 2026
 

LEGAL & GENERAL GROUP PLC
ISIN: GB0005603997
7th September 2026

 

LEI number: 213800JH9QQWHLO99821

 

Legal & General Group Plc (the "Company")
Transaction in Own Shares


The Company announces that from 1st September 2026 up to and including 4th September 2026 it had purchased a total of 4,787,862 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.

Date

Aggregate number of ordinary shares purchased

Highest price paid (per ordinary share)

Lowest price paid (per ordinary share)

Volume weighted average price

 

Trading venue

1st September 2026

 299,085

 292.60

 287.00

 289.89

XLON

1st September 2026

 243,982

 292.30

 287.00

 289.34

BATE

1st September 2026

 231,650

 292.10

 287.00

 289.47

TRQX

1st September 2026

 90,223

 291.60

 287.10

 289.97

AQXE

1st September 2026

 335,060

 292.60

 287.00

 289.74

CHIX

2nd September 2026

 235,533

 291.80

 286.50

 288.71

XLON

2nd September 2026

 222,140

 291.80

 285.80

 288.38

BATE

2nd September 2026

 256,071

 291.80

 285.80

 288.68

TRQX

2nd September 2026

 159,681

 291.80

 285.70

 288.28

AQXE

2nd September 2026

 314,437

 291.80

 285.80

 288.58

CHIX

3rd September 2026

 275,705

 292.30

 286.60

 290.00

XLON

3rd September 2026

 213,315

 292.20

 286.40

 289.57

BATE

3rd September 2026

 231,782

 292.20

 286.40

 289.42

TRQX

3rd September 2026

 179,773

 292.30

 286.40

 289.78

AQXE

3rd September 2026

 299,425

 292.20

 286.40

 289.47

CHIX

4th September 2026

 380,841

 295.30

 291.30

 294.15

XLON

4th September 2026

 180,877

 295.30

 291.30

 294.01

BATE

4th September 2026

 264,942

 295.30

 291.30

 294.00

TRQX

4th September 2026

 98,431

 295.20

 291.70

 294.39

AQXE

4th September 2026

 274,909

 295.30

 291.40

 293.94

CHIX

 

The purchases form part of the Company's share buyback programme announced on 11th March 2026.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,480,446,722 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,480,446,722.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is set out below.

http://www.rns-pdf.londonstockexchange.com/rns/6642T_1-2026-9-7.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings